Skip to main content
Haisco Pharmaceutical Group Co.,Ltd logo

Haisco Pharmaceutical Group Co.,Ltd — Investor Relations & Filings

Ticker · 002653 ISIN · CNE100001BC7 LEI · 300300GRLH34A8GPJ639 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,439 across all filing types
Latest filing 2025-06-09 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002653

About Haisco Pharmaceutical Group Co.,Ltd

https://www.haisco.com

Haisco Pharmaceutical Group Co.,Ltd. focuses on the research, development, production, and commercialization of innovative drugs and high-end generic pharmaceuticals. The company maintains a specialized portfolio across therapeutic areas including anesthesia, parenteral nutrition, anti-infection, cardiovascular health, and endocrine disorders. Key products include advanced anesthetic agents and specialized nutritional injections designed for clinical use. Haisco prioritizes technological innovation through a dedicated R&D infrastructure, targeting the development of small molecule chemical drugs and complex delivery systems. Its operations emphasize high-standard manufacturing processes and the integration of clinical research to address complex medical requirements. The company aims to provide therapeutic solutions that enhance patient care through a commitment to scientific excellence and product quality.

Recent filings

Filing Released Lang Actions
关于获得创新药HSK47977片IND申请《受理通知书》的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement from a pharmaceutical company about receiving an acceptance notice from the National Medical Products Administration for an IND (Investigational New Drug) application for a new drug. It includes details about the drug, its development status, and a risk warning to investors. There is no financial data, no mention of annual or quarterly reports, no management or board changes, no voting results, no legal proceedings, and no other regulatory filings typical of financial or corporate governance documents. The document is an official regulatory announcement related to drug development and approval, which does not fit into financial report categories but is a regulatory announcement. Given the content and length, the best fitting category is Regulatory Filings (RNS).
2025-06-09 Chinese
关于控股股东部分股份解除质押的公告
Major Shareholding Notification Classification · 95% confidence The document is a public announcement regarding the release of a portion of pledged shares by a controlling shareholder. It details the number of shares released from pledge, the shareholder involved, and the pledge status. There is no financial report, earnings data, or management discussion. The document is a regulatory announcement about share pledge status changes, which fits the category of Major Shareholding Notification (MRQ) as it involves significant shareholding changes and pledge status updates by a major shareholder.
2025-06-09 Chinese
关于获得创新药HSK47388片IND申请《受理通知书》的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement from a pharmaceutical company about receiving an acceptance notice from the National Medical Products Administration for an IND (Investigational New Drug) application for a new drug. It includes details about the drug, regulatory acceptance, and risk warnings. The document is short (752 characters) and is an announcement of a regulatory event rather than a financial report or detailed filing. It does not contain financial data, management changes, voting results, or other report types. This fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-06-02 Chinese
关于修订《公司章程》的公告
Governance Information Classification · 95% confidence The document is an announcement regarding the revision of the company's Articles of Association (公司章程). It details specific amendments to the company's bylaws and states that the revisions will be submitted to the shareholders' meeting for approval. There is no financial data, audit information, or report attached. The document is a formal announcement about governance changes, specifically about the company's internal rules and board structure. This fits the category of Governance Information (CGR). The document length is short (1572 characters), and it is not a report publication announcement or a certification. Therefore, the appropriate classification is Governance Information (CGR).
2025-06-02 Chinese
关于召开2025年第二次临时股东会通知的公告
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a notice announcing the convening of the company's 2025 second extraordinary general meeting of shareholders (临时股东会). It details the meeting date, voting procedures, proposals to be voted on, registration information, and proxy voting instructions. There is no financial data, earnings information, or detailed report content. The document is primarily an announcement about the meeting and voting process, not the meeting materials or results themselves. Therefore, it fits the category of a Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings.
2025-06-02 Chinese
董事离职管理制度
Governance Information Classification · 95% confidence The document is titled '董事离职管理制度' which translates to 'Board Director Resignation Management System' and details the procedures, principles, and regulations regarding the resignation and departure of company directors. It includes sections on legal compliance, resignation procedures, responsibilities of departing directors, shareholding management post-resignation, and related governance rules. There is no financial data, earnings information, or report publication mentioned. The content focuses on internal governance policies related to board members' departure. This fits the category of Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2025-06-02 Chinese

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.